PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Plasma-lyte 56 And Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?
Plasma-lyte 56 And Dextrose 5% In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER is dextrose; magnesium acetate tetrahydrate; potassium acetate; sodium chloride. There are nine drug master file entries for this compound. Additional details are available on the dextrose; magnesium acetate tetrahydrate; potassium acetate; sodium chloride profile page.
Summary for PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER
US Patents and Regulatory Information for PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baxter Hlthcare | PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER | dextrose; magnesium acetate tetrahydrate; potassium acetate; sodium chloride | INJECTABLE;INJECTION | 017385-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |